Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Immunology|February 12, 2024
Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion proteinMark A Kroenke, Marta Starcevic Manning, Christina L Zuch de Zafra, et al.
Frontiers in Immunology|July 5, 2024
Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion proteinMark A Kroenke, Marta Starcevic Manning, Christina L Zuch de Zafra, et al.
Journal of Neuro-Oncology|July 23, 2026
Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patternsEmma Sanderson, Katharine Drummond, Anthony Dowling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal CancerTahleesa J Cuda, Andrew D Riddell, Cheng Liu, et al.
Cell Discovery|May 25, 2021
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replicationWen Juan Tu, Robert D McCuaig, Michelle Melino, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 21, 2022
Adult medulloblastoma in an Australian populationSagun Parakh, Amy Davies, Kerryn Westcott, et al.
Cancers|March 25, 2022
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic CancersJenny Dunn, Robert D McCuaig, Abel H Y Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Jason Madore, Jake S O'Donnell, et al.
Immunity|October 14, 2020
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T CellsMatthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, et al.
Pageof 4